4//SEC Filing
BERNSTEIN JEFFREY DANIEL 4
Accession 0000895345-22-000790
CIK 0001759655other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:56 PM ET
Size
5.8 KB
Accession
0000895345-22-000790
Insider Transaction Report
Form 4
BERNSTEIN JEFFREY DANIEL
Director
Transactions
- Sale
Common Stock
2022-11-21$22.56/sh−3,186,888$71,896,193→ 24,826,071 total(indirect: See footnotes)
Footnotes (3)
- [F1]The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.
- [F2]Pursuant to an underwriting agreement, dated November 16, 2022 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 3,186,888 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 18, 2022, which offering was consummated on November 21, 2022 (the "Offering"). The amount above represents the $23.50 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.94 per share of Common Stock.
- [F3]As of November 21, 2022, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 24,826,071 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member.
Documents
Issuer
Privia Health Group, Inc.
CIK 0001759655
Entity typeother
Related Parties
1- filerCIK 0001859499
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:56 PM ET
- Size
- 5.8 KB